CDH1 and gastrointestinal stromal tumor: The expression levels of SNAI2, CDH1, and CDH2 in the GISTs were determined by immunohistochemistry to determine whether the expression levels of SNAI2, CDH1, and CDH2 correlate with the clinicopathological characteristics of GIST patients.